Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ZN-d5 |
Synonyms | |
Therapy Description |
ZN-d5 inhibits BCL-2, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (Annals of Oncology, 32, S594-S595). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ZN-d5 | ZN d5|ZNd5 | BCL2 inhibitor 27 | ZN-d5 inhibits BCL-2, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (Annals of Oncology, 32, S594-S595). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04500587 | Phase I | ZN-d5 | Phase 1 First in Human Study of ZN-d5 as a Single Agent | Completed | POL | HRV | ESP | BGR | AUS | 2 |